1. Home
  2. IMMR vs CRBU Comparison

IMMR vs CRBU Comparison

Compare IMMR & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMR
  • CRBU
  • Stock Information
  • Founded
  • IMMR 1993
  • CRBU 2011
  • Country
  • IMMR United States
  • CRBU United States
  • Employees
  • IMMR N/A
  • CRBU N/A
  • Industry
  • IMMR Computer peripheral equipment
  • CRBU Medicinal Chemicals and Botanical Products
  • Sector
  • IMMR Technology
  • CRBU Health Care
  • Exchange
  • IMMR Nasdaq
  • CRBU Nasdaq
  • Market Cap
  • IMMR 247.2M
  • CRBU 93.0M
  • IPO Year
  • IMMR 1999
  • CRBU 2021
  • Fundamental
  • Price
  • IMMR $8.10
  • CRBU $1.39
  • Analyst Decision
  • IMMR Strong Buy
  • CRBU Strong Buy
  • Analyst Count
  • IMMR 2
  • CRBU 4
  • Target Price
  • IMMR $12.25
  • CRBU $8.50
  • AVG Volume (30 Days)
  • IMMR 507.4K
  • CRBU 1.8M
  • Earning Date
  • IMMR 08-19-2025
  • CRBU 08-05-2025
  • Dividend Yield
  • IMMR 2.23%
  • CRBU N/A
  • EPS Growth
  • IMMR 57.07
  • CRBU N/A
  • EPS
  • IMMR 2.04
  • CRBU N/A
  • Revenue
  • IMMR $163,133,000.00
  • CRBU $9,918,000.00
  • Revenue This Year
  • IMMR $988.71
  • CRBU $12.83
  • Revenue Next Year
  • IMMR $109.72
  • CRBU N/A
  • P/E Ratio
  • IMMR $3.96
  • CRBU N/A
  • Revenue Growth
  • IMMR 338.21
  • CRBU N/A
  • 52 Week Low
  • IMMR $6.47
  • CRBU $0.66
  • 52 Week High
  • IMMR $13.94
  • CRBU $3.00
  • Technical
  • Relative Strength Index (RSI)
  • IMMR 62.95
  • CRBU 62.84
  • Support Level
  • IMMR $7.61
  • CRBU $1.22
  • Resistance Level
  • IMMR $8.15
  • CRBU $1.44
  • Average True Range (ATR)
  • IMMR 0.22
  • CRBU 0.11
  • MACD
  • IMMR 0.03
  • CRBU -0.00
  • Stochastic Oscillator
  • IMMR 92.14
  • CRBU 88.75

About IMMR Immersion Corporation

Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: